(Q34462504)

English

Rationale and design of MinerAlocorticoid Receptor antagonist Tolerability Study-Heart Failure (ARTS-HF): a randomized study of finerenone vs. eplerenone in patients who have worsening chronic heart failure with diabetes and/or chronic kidney diseas

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Rationale and design of MinerAlocorticoid Receptor antagonist Tolerability Study-Heart Failure (ARTS-HF): a randomized study of finerenone vs. eplerenone in patients who have worsening chronic heart failure with diabetes and/or chronic kidney diseas (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

0 references

chronic heart failure

1 reference

based on heuristic

inferred from title

Aldo P. Maggioni

object named as

Aldo P Maggioni

7

0 references

Piotr Ponikowski

object named as

Piotr Ponikowski

8

0 references

Mihai Gheorghiade

4

object named as

Mihai Gheorghiade

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

10

object named as

Faiez Zannad

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1

object named as

Bertram Pitt

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Gerasimos Filippatos

15

object named as

Gerasimos Filippatos

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

5

object named as

Lars Køber

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Stefan D. Anker

2

object named as

Stefan D Anker

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

6

object named as

Henry Krum

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Adriaan A Voors

9

object named as

Adriaan A Voors

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Christina Nowack

11

object named as

Christina Nowack

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Alexander Pieper

13

object named as

Alexander Pieper

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Nina Kimmeskamp-Kirschbaum

14

object named as

Nina Kimmeskamp-Kirschbaum

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

author name string

Michael Böhm

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

So-Young Kim

12

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

publication date

1 February 2015

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

European Journal of Heart Failure

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

224-232

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.218

21 January 2018

Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.218

21 January 2018

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.218

21 January 2018

2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.218

21 January 2018

Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.218

21 January 2018

Use of aldosterone antagonists in heart failure

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.218

21 January 2018

Hospitalizations for heart failure in the United States--a sign of hope

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.218

21 January 2018

Improving postdischarge outcomes in patients hospitalized for acute heart failure syndromes

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.218

21 January 2018

Prognosis and response to therapy of first inpatient and outpatient heart failure event in a heart failure clinical trial: MADIT-CRT.

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.218

21 January 2018

EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot).

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.218

21 January 2018

EURObservational Research Programme: the Heart Failure Pilot Survey (ESC-HF Pilot).

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.218

21 January 2018

Effect of spironolactone on left ventricular systolic and diastolic function in patients with early stage chronic kidney disease

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.218

21 January 2018

Discovery of BAY 94-8862: a nonsteroidal antagonist of the mineralocorticoid receptor for the treatment of cardiorenal diseases

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.218

21 January 2018

Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.218

21 January 2018

Serial NT-proBNP monitoring and outcomes in outpatients with decompensation of heart failure

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.218

21 January 2018

Identifying patients hospitalized with heart failure at risk for unfavorable future quality of life

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.218

21 January 2018

Critical elements of clinical follow-up after hospital discharge for heart failure: insights from the EVEREST trial

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.218

21 January 2018

Molecular pharmacology of the mineralocorticoid receptor: prospects for novel therapeutics

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.218

21 January 2018

PF-03882845, a non-steroidal mineralocorticoid receptor antagonist, prevents renal injury with reduced risk of hyperkalemia in an animal model of nephropathy

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.218

21 January 2018

Effects of aldosterone receptor blockade in patients with mild-moderate heart failure taking a beta-blocker

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.218

21 January 2018

Carvedilol therapy is associated with a sustained decline in brain natriuretic peptide levels in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.218

21 January 2018

Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.218

21 January 2018

Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.218

21 January 2018

Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.218

21 January 2018

Extracellular cardiac matrix biomarkers in patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Stu

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.218

21 January 2018

Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.218

21 January 2018

Randomized, double-blind, multicenter, placebo-controlled study evaluating the effect of aldosterone antagonism with eplerenone on ventricular remodeling in patients with mild-to-moderate heart failure and left ventricular systolic dysfunction

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.218

21 January 2018

Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.218

21 January 2018

N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients.

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.218

21 January 2018

Serum cortisol as a useful predictor of cardiac events in patients with chronic heart failure: the impact of oxidative stress

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.218

21 January 2018

Effect of eplerenone versus spironolactone on cortisol and hemoglobin A1c levels in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.218

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.218

21 January 2018

2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/ Non-ST-Elevation Myocardial Infarction (Updating the 2007 Guideline): a report of the American College of Cardiology Foundation/American Heart Associ

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.218

21 January 2018

Safety and Efficacy of Eplerenone in Patients at High Risk for Hyperkalemia and/or Worsening Renal Function

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.218

21 January 2018

Acute heart failure in the emergency department: Short and long-term outcomes of elderly patients with heart failure

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.218

21 January 2018

Update on Aldosterone Antagonists Use in Heart Failure With Reduced Left Ventricular Ejection Fraction Heart Failure Society of America Guidelines Committee

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.218

7 January 2021

based on heuristic

inferred from DOI database lookup

Finerenone, a novel selective nonsteroidal mineralocorticoid receptor antagonist protects from rat cardiorenal injury

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.218

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial)

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.218

7 January 2021

based on heuristic

inferred from DOI database lookup

Usefulness of clinical and NT-proBNP monitoring for prognostic guidance in destabilized heart failure outpatients

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.218

7 January 2021

based on heuristic

inferred from DOI database lookup

NT-ProBNP reduction percentage during hospital stay predicts long-term mortality and readmission in heart failure patients

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.218

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/EJHF.218

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34462504&oldid=1738898528"